How many insider trades does FilingIQ track for DXR?

FilingIQ tracks 88 Form 4 insider transactions for DXR (DAXOR CORP), covering filings from Jan 15, 2015 onwards. 4 of those were filed in the last 90 days.

Are DXR insiders net buyers or net sellers?

Across the full Form 4 history for DXR, 73 transactions (83%) were open-market purchases and 7 (8%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does DXR insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is DXR in?

DAXOR CORP (DXR) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $54.78M.

DXR insider trading

NasdaqCM Healthcare

DAXOR CORP — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

83% / 8%

Market cap

$54.78M

About DAXOR CORP

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.

Company website: www.daxor.com

DXR insider activity at a glance

FilingIQ has scored 88 insider transactions for DXR since Jan 15, 2015. The most recent filing in our index is dated Apr 8, 2026.

Across the full history, 73 open-market purchases and 7 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on DXR insider trades is 60.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live DXR trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for DXR?: FilingIQ tracks 88 Form 4 insider transactions for DXR (DAXOR CORP), covering filings from Jan 15, 2015 onwards. 4 of those were filed in the last 90 days.
Are DXR insiders net buyers or net sellers?: Across the full Form 4 history for DXR, 73 transactions (83%) were open-market purchases and 7 (8%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does DXR insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is DXR in?: DAXOR CORP (DXR) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $54.78M.

Methodology & sources

Every DXR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.